Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Abernethy

Showing results (1-10 of 221) with videos related to

Pageof 23
Sort By:
Hospital Practice (Office Ed.)|September 30, 1989
Clinical judgment in geriatric hypertensionD R Abernethy
Geriatric Nephrology and Urology|August 6, 1999
Aging effects on drug disposition and effectD R Abernethy
Drug Safety|January 1, 1990
Research challenges, new drug development, preclinical and clinical trials in the ageing populationD R Abernethy
Clinics in Geriatric Medicine|May 1, 1990
Altered pharmacodynamics of cardiovascular drugs and their relation to altered pharmacokinetics in elderly patientsD R Abernethy
Journal of the American Geriatrics Society|October 1, 1987
Development of memory-enhancing agents in the treatment of Alzheimer's diseaseD R Abernethy
Clinical Pharmacology and Therapeutics|November 1, 1991
Workshop on drug utilization review. A practitioner's point of viewD R Abernethy
The American Journal of Cardiology|August 21, 1997
Pharmacologic and pharmacokinetic profile of mibefradil, a T- and L-type calcium channel antagonistD R Abernethy
The American Journal of Cardiology|January 27, 1994
An overview of the pharmacokinetics and pharmacodynamics of amlodipine in elderly persons with systemic hypertensionD R Abernethy
Cardiology|January 1, 1992
Pharmacokinetics and pharmacodynamics of amlodipineD R Abernethy
American Journal of Hypertension|March 1, 1997
Pharmacological properties of combination therapies for hypertensionD R Abernethy
Pageof 23

Showing results (1-10 of 221) with videos related to

Sort By:
Pageof 23
Hospital Practice (Office Ed.)|September 30, 1989
Clinical judgment in geriatric hypertensionD R Abernethy
Geriatric Nephrology and Urology|August 6, 1999
Aging effects on drug disposition and effectD R Abernethy
Drug Safety|January 1, 1990
Research challenges, new drug development, preclinical and clinical trials in the ageing populationD R Abernethy
Clinics in Geriatric Medicine|May 1, 1990
Altered pharmacodynamics of cardiovascular drugs and their relation to altered pharmacokinetics in elderly patientsD R Abernethy
Journal of the American Geriatrics Society|October 1, 1987
Development of memory-enhancing agents in the treatment of Alzheimer's diseaseD R Abernethy
Clinical Pharmacology and Therapeutics|November 1, 1991
Workshop on drug utilization review. A practitioner's point of viewD R Abernethy
The American Journal of Cardiology|August 21, 1997
Pharmacologic and pharmacokinetic profile of mibefradil, a T- and L-type calcium channel antagonistD R Abernethy
The American Journal of Cardiology|January 27, 1994
An overview of the pharmacokinetics and pharmacodynamics of amlodipine in elderly persons with systemic hypertensionD R Abernethy
Cardiology|January 1, 1992
Pharmacokinetics and pharmacodynamics of amlodipineD R Abernethy
American Journal of Hypertension|March 1, 1997
Pharmacological properties of combination therapies for hypertensionD R Abernethy
Pageof 23